Significance of Serum Immunoglobulin G for Leukocytosis and Prognosis in Childhood B-Lineage Acute Lymphoblastic Leukemia

Pediatric Blood and Cancer

Volumn 42, Issue 5, 2004, Pages 421-426

  Potapnev, Michael P ^a   Belevtsev, Michael V ^a   Bortkevich, Ludmila G ^b   Grinev, Vasily V ^c   Martsev, Sergey P ^d   Kravchuk, Zinaida I ^d   Migal, Natalia V ^a   Aleinikova, Oiga V ^a  

^a Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

^b Green Cross Belarus Organization   (Belarus)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

^d INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

Author keywords

Childhood B lineage ALL; Overall survival; Peripheral leukemic cell count; Serum Igs

Indexed keywords

CANCER ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA CELL; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; TURBIDIMETRY;

ADOLESCENT; ANTIBODIES, NEOPLASM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKOCYTOSIS; MALE; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1942454696     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20014     Document Type: Article

References (19)

1. Pui Ch-H, Crist WM. Acute lymphoblastic leukemia. In: Pui Ch-H, editor. Childhood leukemias. New York: Cambridge University Press; 1999. pp 288-312.
2. Donadieu J, Hill C. Early treatment response to chemotherapy as prognostic factor in childhood acute lymphoblastic leukemia: A methodological review. Br J Haematol 2001;115:34-45.
3. Yotnda P, Mintz P, Grigoriadou K, et al. Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells. Exp Hematol 1999;27:1375-1383.
4. Lake DF, Huynh WC, Hersh EM. Natural and induced human antibody response to cancer. Cancer Invest 2000;18:480-489.
5. Welch JC, Lilleyman JS. Immunoglobulin concentrations in untreated lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12:545-549.
6. Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up. Acta Paediatr 1995;84:177-182.
7. Haraldsson A, de Vaan GA, van Dijk WJ, et al. Light chain ratios and concentrations of immunoglobulins G, A, and M in childhood common acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994;11:83-90.
8. Kristinsson VH, Kristinsson JR, Jonmundsson GK, et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol 2001;18:167-172.
9. Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20:451-457.
10. Aleinikova OV. Treatment outcomes of acute lymphoblastic leukemia in Belarus children. Gematol Transfusiol 1997;42:18-21 (in Russian).
11. Kravchuk ZI, Chumanevich AA, Vlasov AP, et al. Two high-affinity monoclonal IgG2a antibodies with different stability and distinct interaction between antigen-binding and protein A-binding sites. J Immunol Methods 1998;217:131-141.
12. Martsev SP, Kravchuk ZI, Vlasov AP, et al. Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from partially structured low pH-induced state. FEB S Lett 1995;361:173-175.
13. Arunachalam B, Talwar GP, Raghupathy R. A simplified cellular ELISA (CELISA) for the detection of antibodies reacting with cell-surface antigens. J Immunol Methods 1990;135:181-189.
14. Liu T, Raetz E, Moos PJ, et al. Diversity of the apoptotic response to chemotherapy in childhood leukemia. Leukemia 2002;16:223-232.
15. Reid MM. Serum immunoglobulins in acute lymphoblastic leukemia. Arch Dis Child 1990;65:1379-1380.
16. Harris LJ, Larson SB, Skaletsky E, et al. Comparison of the conformations of two intact monoclonal antibodies with hinges. Immunol Rev 1998;163:35-43.
17. Gerritsen EJ, van Tol MJ, Ballieux P, et al. Seach for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;17:825-833.
18. Itala M, Helenius H, Nikoskelainen J, et al. Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol 1992;48:266-270.
19. Bohn J, Niemann B, Roggenbuck D, et al. Tumor cell binding by a human monoclonal IgM antibody from the spleen of a non-tumor-associated patient is due to somatic mutations in the VH gene. Clin Exp Immunol 1995;99:376-383.